LUNG
Pulmonx Corporation
NASDAQ · Healthcare · Medical - Devices · US
$2.21
−2.21%Margins
Gross margin
77.1%
EBITDA margin
-49.2%
EBIT margin
-53.0%
Net margin
-55.0%
FCF margin
-35.1%
-122.8%
Return on equity
-41.9%
Return on assets
-48.5%
Return on invested capital
0.75x
Asset turnover
-$30.6M
Cash from operations
$1.30
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026